FDA Expertise Advancing the Understanding of Intentional Genomic Alterations in Animals

February 7, 2020 FDA

FDA analysis published today advances the understanding of intentional genomic alterations in animals.

Previous Article
FDA Authorizes Marketing of First Cardiac Ultrasound Software That Uses Artificial Intelligence to Guide User
FDA Authorizes Marketing of First Cardiac Ultrasound Software That Uses Artificial Intelligence to Guide User

Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professiona...

Next Article
FDA Takes Significant Step in Coronavirus Response Efforts, Issues Emergency Use Authorization for the First 2019 Novel Coronavirus Diagnost
FDA Takes Significant Step in Coronavirus Response Efforts, Issues Emergency Use Authorization for the First 2019 Novel Coronavirus Diagnost

Today, FDA issued an EUA to enable emergency use of CDC’s 2019-nCoV Real-Time RT-PCR Diagnostic Panel. To ...